Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
AP26113
.
Show all posts
Showing posts with label
AP26113
.
Show all posts
Tuesday, October 16, 2012
ARIAD announces initial results from AP26113 Phase 1/2 trial on non-small cell lung cancer
›
We know that, AP26113 (see structure) is a highly potent ALK inhibitor with IC50 of 0.62 nM. As an ALK inhibitor, AP26113 overcomes mu...
›
Home
View web version
